This topic contains a solution. Click here to go to the answer

Author Question: In the one-group pretest-posttest design which of the following threats to internal validity is NOT ... (Read 76 times)

LCritchfi

  • Hero Member
  • *****
  • Posts: 519
In the one-group pretest-posttest design which of the following threats to internal validity is NOT controlled?
 
  a. history
  b. maturation
  c. testing
  d. none are controlled

Question 2

You can quote and analyze online information without asking for permission as long as the information is officially and publicly archived, not password protected and nothing on the site prohibits the use of this information.
 
  a) True
  b) False



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Expo

  • Sr. Member
  • ****
  • Posts: 351
Answer to Question 1

D

Answer to Question 2

d




LCritchfi

  • Member
  • Posts: 519
Reply 2 on: Jul 13, 2018
YES! Correct, THANKS for helping me on my review


ASDFGJLO

  • Member
  • Posts: 335
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Recent studies have shown that the number of medication errors increases in relation to the number of orders that are verified per pharmacist, per work shift.

Did you know?

Although not all of the following muscle groups are commonly used, intramuscular injections may be given into the abdominals, biceps, calves, deltoids, gluteals, laterals, pectorals, quadriceps, trapezoids, and triceps.

Did you know?

Amphetamine poisoning can cause intravascular coagulation, circulatory collapse, rhabdomyolysis, ischemic colitis, acute psychosis, hyperthermia, respiratory distress syndrome, and pericarditis.

Did you know?

Atropine, along with scopolamine and hyoscyamine, is found in the Datura stramonium plant, which gives hallucinogenic effects and is also known as locoweed.

Did you know?

Over time, chronic hepatitis B virus and hepatitis C virus infections can progress to advanced liver disease, liver failure, and hepatocellular carcinoma. Unlike other forms, more than 80% of hepatitis C infections become chronic and lead to liver disease. When combined with hepatitis B, hepatitis C now accounts for 75% percent of all cases of liver disease around the world. Liver failure caused by hepatitis C is now leading cause of liver transplants in the United States.

For a complete list of videos, visit our video library